Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Immune Genes Driving MAFLD Progression and Diagnosis Revealed
September 2025
Emerging evidence points to the role of CD4+ T cell subsets in fuelling MAFLD-related inflammation and fibrosis.
Read more
25 Jul 2025
SGLT-2 Inhibitors May Lower Risk of Serious Liver Events in Cirrhosis
Discover how SGLT-2 inhibitors are linked with reduced risk of serious liver events in cirrhosis patients.
24 Jul 2025
Differences in Hepatitis B Virus- and Alcohol-Related Liver Failure
The study highlights stark contrasts in ACLF triggers across regions: HBV predominates in Eastern countries such as China, while alcohol is the main culprit in the West.
22 Jul 2025
Subclinical Liver Fibrosis Linked to Cardiac Death Risk
Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.
20 Jul 2025
Machine Learning Improves Liver Transplant Prediction Accuracy
While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.
18 Jul 2025
Postbiotics Show Promise in Slowing Liver Fibrosis
While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.
16 Jul 2025
Liver Damage Linked to Brain Magnetite Accumulation
Using superconducting quantum interference device magnetometry, researchers examined the magnetic properties of post-mortem brainstem tissue from four individuals.
16 Jul 2025
Oral Contraceptives Not Linked to Liver Cancer Risk, Large UK Study Finds
Large UK studies show no increased liver cancer risk with oral contraceptives, though longer use may slightly raise risk.
14 Jul 2025
Liver Disease Risk Elevated in Type 2 Diabetes
In this study, MASLD was identified in 50% of the T2DM cohort using non-invasive methods, slightly lower than some global estimates.
Loading posts...
« Previous
1
2
3
4
5
6
…
35
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View